Stocks rebound as the price of oil retreats
Every sector traded higher, with tech leading gains on increased optimism that tankers will be able to pass through the Strait of Hormuz.
The S&P 500, Nasdaq 100, and Russell 2000 all gained around 1% amid a retreat in the price of oil as traders glommed on to some optimistic signs that tankers will be able to pass through the Strait of Hormuz.
The rally was broad-based as all sectors ended the day in the green, with info tech performing the best as investors digested a rosy outlook for Nvidia from CEO Jensen Huang during his keynote GPU Technology Conference address. All Magnificent 7 stocks traded higher.
Bitcoin continued to show resilience, crossing above $74,000. Ethereum also extended its rally as BitMine Immersion Technologies continued its buying spree.
Stocks that moved higher:
Nvidia briefly spiked after Huang said during his keynote GTC address that he sees at least $1 trillion in revenues through 2027, and shares ended the day higher. Memory stocks Sandisk, Western Digital, Seagate Technology Holdings, and Micron rose as well.
Nebius soared after signing an AI infrastructure deal with Meta worth up to $27 billion over five years. Neocloud stocks Cipher Mining, Applied Digital, Riot, IREN, and CoreWeave also rose on the news.
Meta rose following the report of a mass layoff that could slash its headcount to its lowest since 2021.
Micron rose after the memory manufacturer announced that it had closed the acquisition of Powerchip Semiconductor Manufacturing Corporation’s P5 site in Tongluo, Taiwan.
BYD shares climbed on the tailwind of rising oil prices and a report that its Brazil plant received 50,000 vehicle orders from Argentina and Mexico.
IBM popped after Nvidia touted a partnership with watsonx for data processing.
Tesla CEO Elon Musk announced on Saturday that the company’s massive chip manufacturing project, Terafab, will launch in seven days.
Bitcoin’s push toward $74,000 led crypto-linked stocks Coinbase and Strategy higher.
Salesforce gained as the company kicked off a $50 billion buyback with a $25 billion accelerated repurchase.
Structure Therapeutics rose after announcing that its weight-loss pill’s mid-stage results were on par with Eli Lilly’s and Novo Nordisk’s products.
